Obsidian Therapeutics, Inc. Initial Statement of Beneficial Ownership
Alpha Vantage · Stock Titan · · AI-summarised by FinFlash
This article announces the initial statement of beneficial ownership (Form 3) filed by Mark L. Reisenauer for Obsidian Therapeutics, Inc. (OBX) on November 13, 2026. Reisenauer is listed as a director and reported no beneficial ownership of non-derivative or derivative securities. The filing emphasizes transparency regarding insider relationships and beneficial ownership.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.